Arcturus Therapeutics Holdings (ARCT) Leases: 2019-2025
Historic Leases for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to $23.8 million.
- Arcturus Therapeutics Holdings' Leases fell 13.62% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 million, marking a year-over-year decrease of 13.62%. This contributed to the annual value of $26.7 million for FY2024, which is 6.41% down from last year.
- According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Leases is $23.8 million, which was down 3.85% from $24.8 million recorded in Q2 2025.
- Over the past 5 years, Arcturus Therapeutics Holdings' Leases peaked at $34.5 million during Q2 2022, and registered a low of $5.2 million during Q1 2022.
- Moreover, its 3-year median value for Leases was $28.5 million (2023), whereas its average is $27.9 million.
- As far as peak fluctuations go, Arcturus Therapeutics Holdings' Leases decreased by 21.60% in 2022, and later soared by 501.66% in 2023.
- Quarterly analysis of 5 years shows Arcturus Therapeutics Holdings' Leases stood at $5.6 million in 2021, then soared by 479.30% to $32.5 million in 2022, then dropped by 12.43% to $28.5 million in 2023, then dropped by 6.41% to $26.7 million in 2024, then decreased by 13.62% to $23.8 million in 2025.
- Its Leases was $23.8 million in Q3 2025, compared to $24.8 million in Q2 2025 and $25.7 million in Q1 2025.